Biomarkers of dementia in obstructive sleep apnea
dc.contributor.author | Baril, Andrée-Ann | |
dc.contributor.author | Carrier, Julie | |
dc.contributor.author | Lafrenière, Alexandre | |
dc.contributor.author | Warby, Simon | |
dc.contributor.author | Poirier, Judes | |
dc.contributor.author | Osorio, Ricardo S. | |
dc.contributor.author | Ayas, Najib | |
dc.contributor.author | Dubé, Marie-Pierre | |
dc.contributor.author | Petit, Dominique | |
dc.contributor.author | Gosselin, Nadia | |
dc.contributor.author | Canadian Sleep and Circadian Network | |
dc.date.accessioned | 2019-04-09T17:42:05Z | |
dc.date.available | MONTHS_WITHHELD:12 | fr |
dc.date.available | 2019-04-09T17:42:05Z | |
dc.date.issued | 2018-08-13 | |
dc.identifier.uri | http://hdl.handle.net/1866/21538 | |
dc.publisher | Elsevier | fr |
dc.subject | Sleep-disordered breathing | fr |
dc.subject | Alzheimer’s disease | fr |
dc.subject | Vascular dementia | fr |
dc.subject | Mild cognitive impairment | fr |
dc.subject | Cerebrospinal fluid | fr |
dc.subject | Proteomics | fr |
dc.subject | Metabolomics | fr |
dc.subject | Genomics | fr |
dc.subject | Inflammation | fr |
dc.subject | Oxidative stress | fr |
dc.title | Biomarkers of dementia in obstructive sleep apnea | fr |
dc.type | Article | fr |
dc.contributor.affiliation | Université de Montréal. Faculté des arts et des sciences. Département de psychologie | fr |
dc.identifier.doi | 10.1016/j.smrv.2018.08.001 | |
dcterms.abstract | Epidemiologic and mechanistic evidence is increasingly supporting the notion that obstructive sleep apnea is a risk factor for dementia. Hence, the identification of patients at risk of cognitive decline due to obstructive sleep apnea may significantly improve preventive strategies and treatment decisionmaking. Cerebrospinal fluid and blood biomarkers obtained through genomic, proteomic and metabolomic approaches are improving the ability to predict incident dementia. Therefore, fluid biomarkers have the potential to predict vulnerability to neurodegeneration in individuals with obstructive sleep apnea, as well as deepen our understanding of pathophysiological processes linking obstructive sleep apnea and dementia. Many fluid biomarkers linked to Alzheimer’s disease and vascular dementia show abnormal levels in individuals with obstructive sleep apnea, suggesting that these conditions share common underlying mechanisms, including amyloid and tau protein neuropathology, inflammation, oxidative stress, and metabolic disturbances. Markers of these processes include amyloid-β, tau proteins, inflammatory cytokines, acute-phase proteins, antioxydants and oxidized products, homocysteine and clusterin (apolipoprotein J). Thus, these biomarkers may have the ability to identify adults with obstructive sleep apnea at high risk of dementia and provide an opportunity for therapeutic intervention. Large cohort studies are necessary to establish a specific fluid biomarker panel linking obstructive sleep apnea to dementia risk. | fr |
dcterms.isPartOf | urn:ISSN:1087-0792 | fr |
dcterms.isPartOf | urn:ISSN:1532-2955 | fr |
dcterms.language | eng | fr |
UdeM.ReferenceFournieParDeposant | PMID: 30241998 DOI: 10.1016/j.smrv.2018.08.001 | fr |
UdeM.VersionRioxx | Version acceptée / Accepted Manuscript | fr |
oaire.citationTitle | Sleep medicine reviews | |
oaire.citationVolume | 42 | |
oaire.citationStartPage | 139 | |
oaire.citationEndPage | 148 |
Files in this item
This item appears in the following Collection(s)
This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.